Dr. Brent Hinkle, D.O

NPI: 1447434097
Total Payments
$15,112
2024 Payments
$2,210
Companies
50
Transactions
1,010
Medicare Patients
810
Medicare Billing
$132,435

Payment Breakdown by Category

Food & Beverage$15,107 (100.0%)
Education$5.24 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $15,107 1,007 100.0%
Education $5.24 3 0.0%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $2,082 121 $0 (2024)
AstraZeneca Pharmaceuticals LP $1,702 100 $0 (2024)
PFIZER INC. $1,554 112 $0 (2024)
Lilly USA, LLC $1,250 95 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $998.16 74 $0 (2024)
Janssen Pharmaceuticals, Inc $978.93 80 $0 (2024)
Amgen Inc. $770.45 49 $0 (2024)
GlaxoSmithKline, LLC. $711.64 60 $0 (2024)
SANOFI-AVENTIS U.S. LLC $691.22 29 $0 (2023)
ABBVIE INC. $545.56 31 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,210 124 Novo Nordisk Inc ($515.28)
2023 $2,064 118 Novo Nordisk Inc ($457.51)
2022 $1,171 75 Lilly USA, LLC ($232.98)
2021 $1,209 84 AstraZeneca Pharmaceuticals LP ($209.03)
2020 $806.49 52 AstraZeneca Pharmaceuticals LP ($172.02)
2019 $2,254 167 AstraZeneca Pharmaceuticals LP ($262.69)
2018 $2,718 200 Boehringer Ingelheim Pharmaceuticals, Inc. ($368.43)
2017 $2,680 190 SANOFI-AVENTIS U.S. LLC ($461.28)

All Payment Transactions

1,010 individual payment records from CMS Open Payments — Page 1 of 41

Date Company Product Nature Form Amount Type
12/20/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $20.34 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
12/18/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $15.21 General
Category: NEUROSCIENCE
12/12/2024 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $19.65 General
Category: Diabetes
12/11/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $15.90 General
Category: PAIN
12/10/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $20.63 General
Category: Obesity
12/09/2024 PFIZER INC. PREVNAR 20 (Biological), ABRYSVO Food and Beverage In-kind items and services $11.31 General
Category: VACCINES
12/04/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $16.71 General
Category: Diabetes
12/03/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $15.78 General
Category: Cardio-renal
11/21/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $13.19 General
Category: Oncology
11/18/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $18.09 General
Category: Diabetes
11/14/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $18.01 General
11/13/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $15.61 General
Category: PAIN
11/12/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $11.60 General
Category: NEUROSCIENCE
11/06/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $18.31 General
11/05/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $18.68 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/31/2024 PFIZER INC. PREVNAR 20 (Biological), ABRYSVO Food and Beverage In-kind items and services $14.84 General
Category: VACCINES
10/29/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $18.47 General
Category: PSYCHIATRY
10/28/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $17.76 General
Category: Diabetes
10/24/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $19.04 General
Category: Respiratory
10/21/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $14.23 General
Category: Cardio-renal
10/17/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $19.75 General
Category: NEUROSCIENCE
10/16/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $17.49 General
Category: PAIN
10/14/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $17.31 General
Category: GASTROENTEROLOGY
10/10/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $17.50 General
Category: Respiratory
10/09/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $18.31 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 111 2,271 $100,985 $39,983
2022 5 100 1,484 $67,752 $24,921
2021 4 78 1,737 $76,249 $27,973
2020 14 521 2,006 $148,572 $39,558
Total Patients
810
Total Services
7,498
Medicare Billing
$132,435
Procedure Codes
28

All Medicare Procedures & Services

28 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J0897 Injection, denosumab, 1 mg Office 2023 19 2,100 $90,300 $37,561 41.6%
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and Office 2023 24 28 $3,108 $1,024 32.9%
96372 Injection of drug or substance under skin or into muscle Office 2023 26 94 $4,794 $801.39 16.7%
71046 X-ray of chest, 2 views Office 2023 28 34 $2,108 $447.77 21.2%
72100 X-ray of lower and sacral spine, 2-3 views Office 2023 14 15 $675.00 $148.96 22.1%
J0897 Injection, denosumab, 1 mg Office 2022 15 1,320 $56,760 $22,239 39.2%
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and Office 2022 22 24 $2,664 $875.49 32.9%
96372 Injection of drug or substance under skin or into muscle Office 2022 25 80 $4,080 $732.60 18.0%
G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a Office 2022 12 24 $2,016 $663.35 32.9%
71046 X-ray of chest, 2 views Office 2022 26 36 $2,232 $409.98 18.4%
J0897 Injection, denosumab, 1 mg Office 2021 18 1,620 $69,660 $26,474 38.0%
96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention Office 2021 26 80 $4,080 $737.57 18.1%
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and Office 2021 18 20 $2,220 $714.78 32.2%
93005 Routine electrocardiogram (ekg) with tracing using at least 12 leads Office 2021 16 17 $289.00 $46.50 16.1%
J0897 Injection, denosumab, 1 mg Office 2020 15 1,320 $56,760 $19,489 34.3%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 119 152 $34,048 $5,993 17.6%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 157 197 $30,382 $4,990 16.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2020 38 38 $9,158 $4,126 45.1%
99495 Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge Office 2020 14 16 $5,440 $2,037 37.4%
96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention Office 2020 39 85 $4,335 $718.52 16.6%
G0180 Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem Office 2020 17 19 $2,109 $682.06 32.3%
99203 New patient office or other outpatient visit, typically 30 minutes Office 2020 12 12 $2,688 $561.69 20.9%
83036 Hemoglobin a1c level Office 2020 26 27 $702.00 $250.75 35.7%
G0009 Administration of pneumococcal vaccine Office 2020 16 16 $752.00 $248.64 33.1%
71046 X-ray of chest, 2 views Office 2020 24 24 $1,488 $214.89 14.4%

About Dr. Brent Hinkle, D.O

Dr. Brent Hinkle, D.O is a Family Medicine healthcare provider based in Claremore, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1447434097.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brent Hinkle, D.O has received a total of $15,112 in payments from pharmaceutical and medical device companies, with $2,210 received in 2024. These payments were reported across 1,010 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($15,107).

As a Medicare-enrolled provider, Hinkle has provided services to 810 Medicare beneficiaries, totaling 7,498 services with total Medicare billing of $132,435. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Claremore, OK
  • Active Since 12/18/2007
  • Last Updated 05/01/2014
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1447434097

Products in Payments

  • FARXIGA (Drug) $1,039
  • XARELTO (Drug) $784.94
  • JARDIANCE (Drug) $743.73
  • Ozempic (Drug) $600.63
  • TRULICITY (Drug) $564.42
  • ELIQUIS (Drug) $521.41
  • NURTEC ODT (Drug) $444.51
  • CHANTIX (Drug) $399.54
  • Victoza (Drug) $387.29
  • TRELEGY ELLIPTA (Drug) $382.79
  • UBRELVY (Drug) $341.48
  • Rybelsus (Drug) $324.85
  • Wegovy (Drug) $301.38
  • MOUNJARO (Drug) $295.26
  • SYMBICORT (Drug) $275.67
  • SOLIQUA (Drug) $270.48
  • Aimovig (Biological) $259.85
  • STIOLTO RESPIMAT (Drug) $239.35
  • JANUVIA (Drug) $221.78
  • VRAYLAR (Drug) $216.08

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Claremore